Testing effectiveness (Phase 2)Study completedNCT02481297
What this trial is testing
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
Who this might be right for
LeukemiaChronic Lymphocytic LeukemiaLymphocytic Leukemia
M.D. Anderson Cancer Center 7